FDA panel on SSRI antidepressants in pregnancy raises alarms
The U.S. Food and Drug Administration is turning its attention to selective serotonin reuptake inhibitors, a class of antidepressant drugs ...
Read moreDetailsThe U.S. Food and Drug Administration is turning its attention to selective serotonin reuptake inhibitors, a class of antidepressant drugs ...
Read moreDetails
